We don’t abide fake news here on ohmidog!, so we shall not be reporting, at least not with any authority, on reports that the man with the smirk you love to hate — ex-pharmaceutical executive Martin Shkreli — had dog poop hurled in his face at a speaking event Friday.
We can’t report that as fact, which is a shame, because few more deserve poop in their face than the man who drew national attention in 2015 when his company jacked up the price of a life-saving drug from $13.50 to $750 per pill.
TMZ reported unequivocally that the substance hurled was dog poop, while the New York Post said it “reportedly” happened — said report being a Twitter post showing Shkreli having something thrown in his face.
The attack came at a speaking engagement scheduled at UC Davis — with a line up apparently conceived by (as the old Weekly World News used to call him) the Devil himself.
The discussion was to have featured Shkreli and Breitbart columnist/troll/hate speaker extraordinaire Milo Yiannopoulos. Who better to inspire impressionable young minds?
If you don’t believe intellectual thought in this country has been taken over by professional wrestling promoters, consider this: The UC Davis event was one many college campus visits that are part of a “Dangerous Faggot” tour by Yiannopolous.
Actually it wasn’t the devil himself who arranged the event, but the Davis College Republicans Club. The event was canceled after protesters barricaded the venue’s entrance, which resulted in one person getting arrested, according to a university statement.
Yiannopoulos calls himself “the internet’s most fabulous supervillain.” He has also been called the poster boy for new alt right, and his vicious Twitter feeds are filled with racist slurs and bigoted commentary.
Among his more recent victims was actress Leslie Jones.
Shkreli was invited to appear with Yiannopoulos on the UC Davis stop of his tour.
Its upcoming stops include UC Berkeley, UCLA, University of Colorado, and University of Washington.
As for the exact substance Shkreli was showered with, he told Mashable in an email that his security team determined what was thrown were leaves.
“The lack of smell, stain or other obvious findings eliminates the possibility,” Shkreli said.
“There was no poop thrown,” he added, bashing initial reports as “fake news.”
Apparently, while he has no problem with fake and outlandish pricing for pharmaceuticals, fake news is bad in his eyes.
Shkreli resigned as CEO of Turing Pharmaceuticals after his arrest on charges of security fraud.
Posted by John Woestendiek January 16th, 2017 under Muttsblog, videos.
Tags: alt right, appearance, breitbart, ceo, dangerous fag tour, dog poop, event, hurled, intellectual thought, internet, martin shkreli, Milo Yiannopoulos, panel, pharmaceuticals, poop, price gouging, professional wrestling, smirk, smirker, speech, substance, talk, thrown, troll, turing, uc davis, unknown, video, villain
You are hiking down a remote jungle trail in some country where there is quicksand — that legendary kind of quicksand from which there is no escape — when you come across a woman who is hip deep and sinking slowly.
“Oh thank God,” she says when she sees you.
She looks familiar. You smile and ask her name.
“Heather Bresch,” she says.
It takes a moment to register. “Heather Bresch? The CEO of Mylan, the pharmaceutical company that makes the EpiPen?”
“Yes,” she says as she struggles against the quicksand and sinks a little deeper. “I’m vacationing in this country, and I left my luxury villa to take a little walk and this happened. I need help.”
“Clearly you do,” you say. “I’m happy to provide assistance.”
“If you could get that fallen tree limb over there and pass it to me, I think I could pull myself out,” she says, sinking up to the waist as she points.
You walk over and pick up one end of it. “This one?” you say.
“Yes,” she says. “Hurry please.”
You begin sliding the tree limb in her direction.
“This one is $10 million,” you say.
She laughs uncomfortably. “Please, hurry,” she says.
“I’m serious,” you say.
“That’s ridiculous,” she says. “It’s just a tree limb.”
“The EpiPen save lives,” she says.
“So might this stick, if used as directed,” you respond.
Up to her chest in quicksand, she promises to give you the money when she gets out, but you tell her you need it up front.
She struggles to dig into her pockets, causing her to sink up to her neck. As she pulls cash out of her pockets and flings it in your direction, she explains that the six-fold increase in the price of EpiPens was necessary.
“Mylan has spent millions on research and development of the product,” she says. “You can’t expect us to pay for all that ourselves.”
“Oh, so you invented Epinephrine?”
“Well, no, but we’ve spent a lot of money perfecting our sophisticated self-delivery system — in which you plunge a needle in your own leg and push down on the stopper, administering a pre-measured, life-saving dosage.”
“And if people just measured their own, and used an old fashioned syringe, what would be the actual cost?” you ask.
“Oh, maybe about $2.29, but that’s not the point. The point is much effort and significant expense went into creating that delivery system — things like shipping and handling and lobbying and designer white lab coats, all part of our noble effort to keep people from dying from allergic reactions to bee stings and such.”
She throws a final fistful of cash out of the quicksand. “There,” she says, “that’s $10 million. Now please slide that stick to me.”
“Oh, I’m so sorry,” you say. “The $10 million price was five minutes ago. It has gone up since then – to $20 million.”
“That’s more than I make in a year,” she protests.
“We are not talking about my salary,” she says. “Now, please, the stick. Anyone can hand someone a stick. It costs nothing.”
“Bear in mind,” you say, as the quicksand rises to her mouth, “you are not so much paying for the stick as you are paying for the delivery system. Just look at me as a monopoly providing a needed service. And the cool part is I just stumbled upon my monopoly. I didn’t need help from my senator-father, or to spend millions lobbying for it.”
You watch as the quicksand covers her nose, and then her eyes.
As the top of her head disappears, you plunge the stick into the muck. She grabs on and hauls herself out. Though coughing and exhausted, she manages a laugh, and you are pretty sure you hear her call you a “sucker.”
She crawls about picking up her money as you walk away — but not before noticing an anaconda is slithering up to her from behind, and an alligator is creeping towards her from the river, and a swarm of Zika-carrying mosquitoes is headed her way.
You are not worried about her. She is where she belongs:
With all the other predators.
Posted by John Woestendiek August 26th, 2016 under Muttsblog.
Tags: 19 million, allergies, ceo, costs, death, drugs, epinephrine, epipen, fable, fetch, fictional, gouging, health, heather bresch, insurance, mylan, pharma, pharmaceuticals, predators, quicksand, salary, stick
It’s the one-year anniversary for 120 beagles who, around this time last year, learned the true meaning of independence.
Up until then, even here in the land of the free, they weren’t.
Instead, like thousands of other beagles bred and born for the sole purpose of laboratory use, they’d never experienced what most dogs take for granted — things like grass and dirt and running — and were destined, once their use in testing was complete, for something quite contrary to a loving home.
The beagles had been left locked in a research facility operated by Aniclin Preclinical Services in Warren County, N.J. after its parent pharmaceutical company went bankrupt. When their situation came to light, a judge order the dogs turned over to rescue groups.
One year ago, a group of them were welcomed to Pets Alive Animal Sanctuary in New York, where work began on socializing them so they could be adopted out as family pets.
This coming Sunday, some of them will gather for a reunion.
About 35 of the adopters stay in touch on Facebook, offering support and following each others progress through photos and stories.
They — and any of the others who adopted a “freegle,” as they are prone to calling the dogs rescued from the laboratory — are gathering July 10, from 12:30 to 4 p.m., at Kennedy Dells Park, 355 North Main Street in New City, New York.
Among those attending will be a beagle named Grace, who has her own Facebook page, called Saving Grace. Grace’s owner said that while word of the reunion has gotten out among those who stay in touch, other beagles adopted from the group are also invited, as well as everyone else who participated in rescuing them.
Shelters, sanctuaries, volunteers and staff are “most welcome to attend and meet the families and hear the stories of how the Freegles have been adjusting to the good life.”
(For questions or to RSVP, send an email to firstname.lastname@example.org.)
I met several lab beagles while researching my book — including some flourescent beagle clones in South Korea. In Texas, I interviewed the woman who cared for the beagles used in attempting to clone a dog at Texas A&M University.
Jessica Harrison, a graduate student at the time, was in charge of socializing the beagles and finding adoptive homes for them — not usually the case or fate of laboratory beagles — after their services in the lab were no longer required.
“What they teach them is to be still,” she told me. “As puppies, they teach them to just freeze when a person messes with them. We had to kindo of undo that and say, ‘No,we want you to move around and be excited.’
“We slowly exposed them to all the things they’d be exposed to in a family home — like TVs, mirrors, grass, trees, flowers, birds and bees. These dogs had never seen any of that. You put them down on the grass, and they’re like, ‘What’s this?’ It was kind of overwheliming. You get used to it, but at first it’s like, these are dogs, how can they not know these things?”
The use of dogs in laboratory research was declining, but it has jumped up in recent years, with much of the increase due to advancements in, and the promise of, gene therapy.
(Photos: Top photo from the Facebook page of Freegles Justice and Skipper; bottom photo by John Woestendiek)
Posted by John Woestendiek July 4th, 2011 under Muttsblog.
Tags: adopt, adopted, aniclin, animal sanctuary, beagles, best freinds, cloning, dog inc., dogs, experiments, flourescent, freed, freegle reunion, freegles, kennedy dells park, lab animals, lab beagles, laboratory, medical, new city, new jersey, new york, pets, pets alive, pharmaceuticals, rescue, research, reunion, sanctuary, science, shelter, warren county
On Friday, the beagles — owned by a research facility in New Jersey whose parent pharmaceutical company went into bankruptcy — were released to the care of animal rescue groups that, after socializing them, hope to adopt them out as family pets.
Beagles are bred especially for use in medical experiments and are used in research because of their affable and passive natures, their relative lack of inherited health problems and their mid-range size. These particular beagles are estimated to be between two and five years of age and have lived their entire lives in a laboratory.
Best Friends Animal Society headquartered in Kanab, Utah, and Pets Alive Animal Sanctuary, based in Middletown, N.Y., and Elmsford, N.Y., worked together on rescuing the beagles, who had been left locked in the facility operated by Aniclin Preclinical Services in Warren County, N.J.
The facility closed in April, after Aniclin’s parent pharmaceutical company couldn’t pay its bills, according to the Times Herald-Record in New York’s Hudson Valley.
A judge ruled that the beagles could be handed over to animal rescue organizations. Fifty-five primates were also removed from the facility and sent to a simian rescue organization
Pets Alive Animal Sanctuary welcomed the beagles to their new home this weekend, decorated in red, white and blue.
Best Friends, according to a press release, was made aware of the beagles’ dilemma through its Community Animal Assistance national helpline, which fields requests to help animals from around the country. Best Friends contacted Pets Alive, a sanctuary in the Lower Hudson Valley region of New York, which offered to take ownership of the dogs. Several other animal rescue organizations have stepped forward, each offering to take some of the beagles.
Best Friends is paying for veterinary care, food and transportation of the dogs from the facility. It will be bringing back as many as 30 dogs to its sanctuary in Utah, including those who may need more time and help before transitioning into family living.
“Best Friends is teaming up with Pets Alive in the New York area to help these beagles get the fresh start they deserve … one that’s long overdue,” said Judah Battista of Best Friends Animal Society.
“These dogs have been in a laboratory, too long without friends,” she said. “Since these dogs have never had the opportunity to discover their true lovable, comical, often boisterous nature, which makes beagles such a favorite family dog, Pets Alive and Best Friends are committed to helping these dogs discover their true personalities.”
“In this case, the cruel and unnecessary practice of animal testing was compounded by the abandonment of these innocent victims,” said Kerry Clair, executive co-director of Pets Alive Animal Sanctuary.
People who live near Pets Alive in Middletown, N.Y., are invited to volunteer their time to help feed, care for and socialize the beagles. To do so contact email@example.com.
Posted by John Woestendiek July 4th, 2010 under Muttsblog.
Tags: aniclin, animals, beagles, best friends, best friends animal society, chemicals, dogs, donate, experiments, free, freed, independence, lab, laboratory, new jersey, news, ohmidog!, pets, pets alive, pharmaceuticals, receivership, released, research, sanctuary, utah, vounteer, warren county